|
[1]
|
Qi, J., Shi, L.Y., Wu, Y., et al. (2019) Epigenetic Silencing of miR-335 Induces Migration by Targeting Insulin-Like Growth Factor-1 Receptor in Multiple Myeloma. Leukemia & Lymphoma, 13, 1-11.
[Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Long, S., Long, S., He, H., et al. (2019) MicroRNA-765 Is Pregulated in Multiple Myeloma and Serves an Oncogenic Role by Directly Targeting SOX6. Experimental and Therapeutic Medicine, 17, 4741-4747.
[Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Zhang, L., Zhou, L., Shi, M., et al. (2018) Downregulation of miRNA-15a and miRNA-16 Promote Tumor Proliferation in Multiple Myeloma by Increasing CABIN1 Expression. Oncology Letters, 15, 1287-1296.
[Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Jang, H., Choi, S.Y., Cho, E.J., et al. (2009) Cabin1 Restrains p53 Activity on Chromatin. Nature Structural & Molecular Biology, 16, 910-915.
[Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Lu, Y., Wu, D., Wang, J., et al. (2016) miR-320a Regulates Cell Proliferation and Apoptosis in Multiple Myeloma by Targeting Pre-B-Cell Leukemia Transcription Factor 3. Biochemical and Biophysical Research Communications, 473, 1315-1320.
[Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Wang, N., Liang, X., Yu, W., et al. (2018) Differential Expression of MicroRNA-19b Promotes Proliferation of Cancer Stem Cells by Regulating the TSC1/mTOR Signaling Pathway in Multiple Myeloma. Cellular Physiology and Biochemistry, 50, 1804-1814.
[Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Zhang, X., Chen, Y., Zhao, P., et al. (2017) MicroRNA-19a Functions as an Oncogene by Regulating PTEN/AKT/pAKT Pathway in Myeloma. Leukemia & Lymphoma, 58, 932-940.
[Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Yuan, J., Su, Z., Gu, W., et al. (2019) MiR-19b and miR-20a Suppress Apoptosis, Promote Proliferation and Induce Tumorigenicity of Multiple Myeloma Cells by Targeting PTEN. Cancer Biomark, 24, 279-289.
[Google Scholar] [CrossRef]
|
|
[9]
|
Amodio, N., Stamato, M.A., Gullà, A.M., et al. (2016) Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma. Molecular Cancer Therapeutics, 15, 1364-1375.
[Google Scholar] [CrossRef]
|
|
[10]
|
Wu, S., He, X., Li, M., et al. (2016) MiRNA-34a Overexpression Inhibits Multiple Myeloma Cancer Stem Cell Growth in Mice by Suppressing TGIF2. American Journal of Translational Research, 8, 5433-5443.
|
|
[11]
|
Amodio, N., Gallo Cantafio, M.E., Botta, C., et al. (2019) Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. Cancers (Basel), 11, 236.
[Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Yuan, X., Ma, R., Yang, S., et al. (2019) miR-520g and miR-520h Overcome Bortezomib Resistance in Multiple Myeloma via Suppressing APE1. Cell Cycle, 18, 1660-1669.
[Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Xu, Y.Y., Song, Y.Q., Huang, Z.M., et al. (2019) MicroRNA-26a Inhibits Multiple Myeloma Cell Growth by Suppressing Cyclin-Dependent Kinase 6 Expression. The Kaohsiung Journal of Medical Sciences, 35, 277-283.
[Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Gupta, N., Kumar, R., Seth, T., et al. (2019) Clinical Significance of Circulatory microRNA-203 in Serum as Novel Potential Diagnostic Marker for Multiple Myeloma. Journal of Cancer Research and Clinical Oncology, 145, 1601-1611.
[Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Jiang, Y., Luan, Y., Chang, H., et al. (2018) The Diagnostic and Prognostic Value of Plasma microRNA-125b-5p in Patients with Multiple Myeloma. Oncology Letters, 16, 4001-4007.
[Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Che, F., Wan, C., Dai, J., et al. (2019) Increased Expression of miR-27 Predicts Poor Prognosis and Promotes Tumorigenesis in Human Multiple Myeloma. Bioscience Reports, 39, BSR20182502.
[Google Scholar] [CrossRef]
|
|
[17]
|
Ren, Y., Li, X., Wang, W., et al. (2017) Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients. Clinical Lymphoma, Myeloma and Leukemia, 17, 415-423.
[Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Hao, M., Zang, M., Zhao, L., et al. (2016) Serum High Expression of miR-214 and miR-135b as Novel Predictor for Myeloma Bone Disease Development and Prognosis. Oncotarget, 7, 19589-19600.
[Google Scholar] [CrossRef] [PubMed]
|